Skip to main content

CVS Health Value Stock - Dividend - Research Selection

Cvs health

ISIN: US1266501006 , WKN: 859034

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?

2025-11-26
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Building A $100,000 Dividend Portfolio: Maximizing SCHD's Income With November's Top High-Yield Stocks

2025-11-26
This article presents a diversified $100,000 high-yield dividend portfolio for November 2025, blending income, dividend growth, and reduced volatility.

These stocks have strong total shareholder returns, says Morgan Stanley

2025-11-26
Morgan Stanley screened for names that have robust returns, including dividends and stock buybacks.

How Recent Developments Are Shaping the CVS Health Investment Story

2025-11-26
CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of tempered optimism following recent earnings. Analysts cite a mix of upbeat and cautious factors shaping their outlooks; the modest adjustment captures both lingering industry challenges and growing confidence in the company’s execution. Stay tuned to learn how you can keep informed on further shifts in analyst sentiment as the narrative for CVS Health continues to...

CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?

2025-11-25
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.

Abortion pill makers brace for restrictions a year after Trump's election

2025-11-25
Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.

Hitting the $1 million milestone in your 401(k) isn't as big a deal as you might think. How to keep more of your savings

2025-11-24
Taxes and inflation are packing a one-two punch.

Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent

2025-11-24
Ubisoft gains as Tencent invests in studio behind Assassin’s Creed. Trump expected to announce 'framework' to cut health costs. Michael Burry's big stay-tuned reveal is a Substack?

Trump Calls Obamacare Insurers Fat and Rich. Investors See Them as Vulnerable.

2025-11-23
Healthcare politics and investing might as well be living in alternate universes. President Trump and some Republicans have been describing Obamacare as a gravy train for insurers. Trump’s latest broadside slammed “big, fat, rich insurance companies who have made trillions,” and he urged Congress to send healthcare subsidies directly to patients instead.

BDJ: A Value-Oriented Fund With 8.4% Yield And Nearly 7% Discount

2025-11-23
BDJ is a CEF that invests in the equity of large-cap, dividend-paying, and value-oriented stocks, mostly from the Russell-1000 Value index. Read more on BDJ here.